Inhibition of 5-lipoxygenase pathway attenuates acute liver failure by inhibiting macrophage activation

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Li, Lu ^a   Liu, Yi Rong ^a   Gao, Shan ^a   Li, Jun Feng ^a   Li, Shan Shan ^a   Zhang, Dan Dan ^a   Liu, Shuang ^a   Bai, Li ^a   Zheng, Su Jun ^a   Duan, Zhong Ping ^a   Qi, Min ^b   Chen, Yu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ARACHIDONATE 5 LIPOXYGENASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DOCEBENONE; GALACTOSAMINE; LEUKOTRIENE B4; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; 2,3,5-TRIMETHYL-6-(12-HYDROXY-5,10-DODECADIYNYL)-1,4-BENZOQUINONE; BENZOQUINONE DERIVATIVE; LIPOXYGENASE INHIBITOR;

ACUTE LIVER FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CELL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME INHIBITION; HISTOPATHOLOGY; LIVER NECROSIS; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION INHIBITION; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; ANIMAL; BLOOD; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM; MORTALITY; NECROSIS; PATHOLOGY; SIGNAL TRANSDUCTION; ULTRASTRUCTURE;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; BENZOQUINONES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; LIPOPOLYSACCHARIDES; LIPOXYGENASE INHIBITORS; LIVER FAILURE, ACUTE; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; NECROSIS; RATS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903648093     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/697560     Document Type: Article

References (35)

1. Lee W. M., Squires R. H. Jr., Nyberg S. L., Doo E., Hoofnagle J. H., Acute liver failure: summary of a workshop. Hepatology 2008 47 4 1401 1415 2-s2.0-42249102412 10.1002/hep.22177 (Pubitemid 351547926)
2. Stravitz R. T., Kramer D. J., Management of acute liver failure. Nature Reviews Gastroenterology and Hepatology 2009 6 9 542 553 2-s2.0-69949104581 10.1038/nrgastro.2009.127
3. Grodzicki M., Kotulski M., Leonowicz D., Zieniewicz K., Krawczyk M., Results of treatment of acute liver failure patients with use of the prometheus FPSA system. Transplantation Proceedings 2009 41 8 3079 3081 2-s2.0-70350496676 10.1016/j.transproceed.2009.08.024
4. Marudanayagam R., Shanmugan V., Gunson B., Mirza D. F., Mayer D., Buckels J., Bramhall S. R., Aetiology and outcome of acute liver failure. HPB 2009 11 5 429 434 2-s2.0-70349527872 10.1111/j.1477-2574.2009.00086.x
5. Hiramatsu A., Takahashi S., Aikata H., Azakami T., Katamura Y., Kawaoka T., Uka K., Yamashina K., Takaki S., Kodama H., Jeong S. C., Imamura M., Kawakami Y., Chayama K., Etiology and outcome of acute liver failure: retrospective analysis of 50 patients treated at a single center. Journal of Gastroenterology and Hepatology 2008 23 8 1216 1222 2-s2.0-48549100813 10.1111/j.1440-1746.2008.05402.x
6. Canbay A., Jochum C., Bechmann L. P., Festag S., Gieseler R. K., Yüksel Z., Lütkes P., Saner F. H., Paul A., Gerken G., Acute liver failure in a metropolitan area in Germany: a retrospective study (2002-2008). Zeitschrift für Gastroenterologie 2009 47 9 807 813 2-s2.0-68149157702 10.1055/s-0028-1109058
7. Akdogan M., Camci C., Gurakar A., Gilcher R., Alamian S., Wright H., Nour B., Sebastian A., The effect of total plasma exchange on fulminant hepatic failure. Journal of Clinical Apheresis 2006 21 2 96 99 2-s2.0-33750113301 10.1002/jca.20064
8. Davenport A., Will E. J., Davison A. M., Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney International 1993 41 S245 S251 2-s2.0-0000567831
9. Sato S., Suzuki K., Takikawa Y., Endo R., Omata M., Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: an analysis of 1309 cases in a 15-year national survey. Hepatology Research 2004 30 3 155 161 2-s2.0-10644272505 10.1016/j.hepres.2004. 08.003 (Pubitemid 39654746)
10. Sekido H., Matsuo K., Takeda K., Ueda M., Morioka D., Kubota T., Tanaka K., Endo I., Togo S., Shimada H., Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure. Transplantation Proceedings 2004 36 8 2355 2356 2-s2.0-9244245758 10.1016/j.transproceed.2004. 06.040 (Pubitemid 39550842)
11. Matsui A., Mochida S., Ohno A., Nagoshi S., Hirose T., Fujiwara K., Plasma osteopontin levels in patients with fulminant hepatitis. Hepatology Research 2004 29 4 202 206 2-s2.0-4043094014 10.1016/j.hepres.2004.03.009 (Pubitemid 39066204)
12. Hiraoka A., Horiike N., Akbar S. M. F., Michitaka K., Matsuyama T., Onji M., Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure. Journal of Gastroenterology 2005 40 1 52 56 2-s2.0-20444416016 10.1007/s00535-004-1493-8 (Pubitemid 40796332)
13. Møller H. J., Grønbæk H., Schiødt F. V., Holland-Fischer P., Schilsky M., Munoz S., Hassanein T., Lee W. M., Soluble CD163 from activated macrophages predicts mortality in acute liver failure. Journal of Hepatology 2007 47 5 671 676 2-s2.0-34848840320 10.1016/j.jhep.2007. 05.014 (Pubitemid 47503425)
14. Titos E., Clària J., Planagumà A., López-Parra M., González-Périz A., Gaya J., Miquel R., Arroyo V., Rodés J., Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells. Journal of Leukocyte Biology 2005 78 4 871 878 2-s2.0-25644456834 10.1189/jlb.1204747 (Pubitemid 41384403)
15. Titos E., Clària J., Planagumà A., López-Parra M., Villamor N., Párrizas M., Carrió A., Miquel R., Jiménez W., Arroyo V., Rivera F., Rodés J., Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis. The FASEB Journal 2003 17 12 1745 1747 2-s2.0-0141595006
16. Ito S., Ito Y., Katagiri H., Suzuki T., Hoka S., Yokomizo T., Shimizu T., Majima M., Leukotriene b 4/leukotriene b 4 receptor pathway is involved in hepatic microcirculatory dysfunction elicited by endotoxin. Shock 2008 30 1 87 91 2-s2.0-51549093018 10.1097/SHK.0b013e31815d06a1
17. Yamate J., Kumagai D., Tsujino K., Nakatsuji S., Kuwamura M., Kotani T., Sakuma S., LaMarre J., Macrophage populations and apoptotic cells in the liver before spontaneous hepatitis in Long-Evans Cinnamon (LEC) rats. Journal of Comparative Pathology 1999 120 4 333 346 2-s2.0-0033135577 10.1053/jcpa.1998. 0282 (Pubitemid 29204487)
18. Woods J. W., Evans J. F., Ethier D., Scott S., Vickers P. J., Hearn L., Heibein J. A., Charleson S., Singer I. I., 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. Journal of Experimental Medicine 1993 178 6 1935 1946 2-s2.0-0027504207 10.1084/jem.178.6.1935 (Pubitemid 23344852)
19. Lu L., Chunhua M., Yu C., The expression and the role of 5-lipoxygenase in rats of acute liver failure. Beijing Medical Infection and Communication Research 2013 35 1007 1010
20. Taniguchi H., Yomota E., Nogi K., Onoda Y., Effects of anti-ulcer agents on ethanol-induced gastric mucosal lesions in D-galactosamine-induced hepatitis rats. Arzneimittel-Forschung 2002 52 8 600 604 2-s2.0-0036354025
21. Decker K., Keppler D., Galactosamine induced liver injury. Progress in Liver Diseases 1972 4 183 199 2-s2.0-0015442199
22. Konishi Y., Shinozuka H., Farber J. L., The inhibition of rat liver nuclear ribonucleic acid synthesis by galactosamine and its reversal by uridine. Laboratory Investigation 1974 30 6 751 756 2-s2.0-0016169551
23. Urade M., Izumi R., Kitagawa H., Inhibition of 5-lipoxygenase promotes the regeneration of the liver after partial hepatectomy in normal and icteric rats. Hepatology 1996 23 3 544 548 2-s2.0-0029918037 (Pubitemid 26087169)
24. Durmaz R., Kasapoglu E., Vural M., Çolak Ö., Aydar Y., Bal C., Atasoy M. A., AA-861 appears to suppress leukocyte infiltration induced by traumatic brain injury in rats. Neurosciences 2008 13 3 217 226 2-s2.0-47749112817 (Pubitemid 352031614)
25. Funk C. D., Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001 294 5548 1871 1875 2-s2.0-0035976575 10.1126/science.294. 5548.1871 (Pubitemid 33101574)
26. Farzaneh-Far R., Moore K., Cysteinyl-leukotrienes and the liver. Prostaglandins and Other Lipid Mediators 2003 72 1-2 35 50 2-s2.0-3042636649 10.1016/S1098-8823(03)00076-5 (Pubitemid 39220484)
27. Keppler D., Huber M., Baumert T., Leukotrienes as mediators in diseases of the liver. Seminars in Liver Disease 1988 8 4 357 366 2-s2.0-0024230817 (Pubitemid 19045634)
28. Keppler D., Lesch R., Reutter W., Decker K., Experimental hepatitis induced by d-galactosamine. Experimental and Molecular Pathology 1968 9 2 279 290 2-s2.0-0014336860
29. Kawada N., Ueda N., Mizoguchi Y., Kobayashi K., Monna T., Morisawa S., Ishimura K., Suzuki T., Yamamoto S., Increased 5-lipoxygenase activity in massive hepatic cell necrosis in the rat correlates with neutrophil infiltration. Hepatology 1992 16 2 462 468 2-s2.0-0026776392 10.1002/hep.1840160227
30. Decker K., Eicosanoids, signal molecules of liver cells. Seminars in Liver Disease 1985 5 2 175 190 2-s2.0-0022058488
31. Laskin D. L., Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chemical Research in Toxicology 2009 22 8 1376 1385 2-s2.0-68949122649 10.1021/tx900086v
32. Kotoh K., Kato M., Enjoji M., A new treatment strategy for acute liver failure. World Journal of Hepatology 2010 2 11 395 400
33. Lu L., Yuan G., Yu C., The morphological changes and the role of macrophages in rats of acute liver failure. Chinese Hepatology 2013 18 597 600
34. Koay M. A., Gao X., Washington M. K., Parman K. S., Sadikot R. T., Blackwell T. S., Christman J. W., Macrophages are necessary for maximal nuclear factor- B activation in response to endotoxin. American Journal of Respiratory Cell and Molecular Biology 2002 26 5 572 578 2-s2.0-0036010521 (Pubitemid 34315865)
35. Matsumaru K., Ji C., Kaplowitz N., Mechanisms for sensitization to TNF-induced apoptosis by acute glutathione depletion in murine hepatocytes. Hepatology 2003 37 6 1425 1434 2-s2.0-0038241619 10.1053/jhep.2003.50230 (Pubitemid 36667323)